BIOTECH TARGET N V, Ten Percent Owner at Cidara Therapeutics, holds 0.00 shares in Molecular Templates (Ticker: MTEM), holds 9.93M shares in MacroGenics (Ticker: MGNX), holds 8.73M shares in Radius Health (Ticker: ~RDUS). Most recently, BIOTECH TARGET N V Sold ― shares of Molecular Templates on Nov 18, 2024 for an estimated value of 844.68K.
What is the percentage of profitable transactions made by BIOTECH TARGET N V?
The percentage of profitable transactions made by BIOTECH TARGET N V is 32%.
What is the average return per transaction made by BIOTECH TARGET N V?
The average return per transaction made by BIOTECH TARGET N V is -29.50%.
What stocks does BIOTECH TARGET N V hold?
BIOTECH TARGET N V holds: CDTX, ESPR, ~RDUS, MTEM, MGNX stocks.
What was BIOTECH TARGET N V’s latest transaction?
BIOTECH TARGET N V latest transaction was an Informative Sell of $844.68K.
What was BIOTECH TARGET N V's most profitable transaction?
BIOTECH TARGET N V’s most profitable transaction was an Informative Buy of MGNX stock on February 16, 2023. The return on the trade was 228.50%.
What is BIOTECH TARGET N V's role in Cidara Therapeutics?
BIOTECH TARGET N V's role in Cidara Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.